SIMPLY INNOVATIVE PRODUCTS, INC. (FORMERLY COASTAL INTEGRATED SERVICES, INC.) FINANCIAL STATEMENTS March 31, 2018

Similar documents
COASTAL INTEGRATED SERVICES, INC. (FORMERLY SIMPLY LIDS) FINANCIAL STATEMENTS December 31, 2016

GREEN CURES AND BOTANCAL DISTRIBUTION, INC.

List any stock split dividend, recapitalization, merger, acquisition, spin-off, or reorganization either

///// GoIP Global. Inc FINANCIAL STATEMENTS. For the Years ended. December 31, 2017 and December 31, 2016

SNAPWIRE MEDIA, INC. NOTES TO THE FINANCIAL STATEMENTS

OPERATING ACTIVITIES Net Income

Solos Endoscopy, Inc.

RJD Green, Inc. Balance Sheets As of November 30, 2018, and August 31, 2018

NORTH BAY RESOURCES INC. UNAUDITED BALANCE SHEETS AS OF JUNE 30, 2018 AND DECEMBER 31, 2017

FORM 10-Q. Singlepoint, Inc. (Name of small business issuer in its charter)

IPURE LABS INC. AND SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE AND THREE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016 (UNAUDITED)

Creative Edge Nutrition, Inc. and Subsidiaries. Consolidated Financial Statements

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C FORM 10-Q

Southern ITS International, Inc. Consolidated Financial Statements For the Years Ended December 31, 2016 and 2015 (Unaudited)

BIG CAT ENERGY CORPORATION BALANCE SHEET

Kraig Biocraft Laboratories, Inc

Kraig Biocraft Laboratories, Inc

HYLETE, INC. FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2016 AND 2015

BENEFICIAL HOLDINGS, INC. CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2013 AND 2012 AND FOR THE YEARS THEN ENDED

W TECHNOLOGIES, INC. Financial Statements. April 30, 2016

WATER TECHNOLOGIES INTERNATIONAL INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2017 (UNAUDITED)

AIMRITE HOLDINGS CORP. UNADUITED FINANCIAL STATEMENTS December 31, 2017

CANNAMED 4PETS INC. (A DEVELOPMENT STAGE COMPANY) FINANCIAL STATEMENTS NOVEMBER 30, 2015

Southern ITS International, Inc. (DBA Evolution Enterprises, Inc.) Consolidated Financial Statements June 30, 2017 and December 31, 2016 (Unaudited)

AMFIL TECHNOLOGIES INC. FINANCIAL STATEMENTS. FOR THE 3 MONTHS ENDED March 31 st 2018 & 2017 (UNAUDITED) PREPARED BY MANAGEMENT

INTERTECH SOLUTIONS INC. Symbol: ITEC

BIOTRICITY, INC. (Name of Registrant in Its Charter)

CLICKSTREAM CORP FORM 10-Q. (Quarterly Report) Filed 02/22/16 for the Period Ending 12/31/15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q

SUPERNOVA ENERGY, INC. Symbol: SPRN

DRONE USA, INC. AND SUBSIDIARIES Consolidated Financial Statements September 30, 2016 and 2015

Boss Holdings, Inc. and Subsidiaries. Consolidated Financial Statements December 30, 2017

SUTIMCo International, Inc.

Bitcoin Services, Inc. Condensed Consolidated Balance Sheet December 31, (unaudited)

LANDSTAR DEVELOPMENT GROUP INC. FORMERLY STERLING OIL AND GAS COMPANY

Sondors Electric Car Company Index to Financial Statements

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q WIZARD WORLD, INC.

Kraig Biocraft Laboratories, Inc

March 31, American Nortel Communications, Inc. (Exact name of issuer as specified in its charter)

Digital Utilities Ventures, Inc.

LANDSTAR, INC. AND SUBSIDIARIES

ASSETS. Furniture and equipment, net 86,361 86,726

VGTEL, INC. BALANCE SHEET September 30, 2018

Solos Endoscopy, Inc.

PACIFIC GOLD CORP. (Exact name of registrant as specified in charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C FORM 10-Q

Contents Letter to Stockholders... 2 Financial Statements...4 Management s Discussion...22 Selected Financial Data...28 Corporate Information...

VIADERMA INC. AND SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2017 (UNAUDITED)

CLICKSTREAM CORP. (Exact name of registrant as specified in its charter)

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Life Clips, Inc. Form: 10-Q. Date Filed:

CAKNOW TECHNOLOGY INC. FINANCIAL STATEMENTS AS OF AND FOR THE PERIOD ENDED DECEMBER 31, 2016

VICTORY MARINE HOLDINGS CORP. AND SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 (UNAUDITED)

ANNUAL REPORT AMERICAN PREMIUM WATER CORPORATION

Oracle Corporation (Exact name of registrant as specified in its charter)

FORM 10-Q. TERRA TECH CORP. (Exact Name of Registrant as Specified in its Charter)

The Goldfield Corporation

ANNUAL REPORT AMERICAN PREMIUM WATER CORPORATION YEAR ENDED DECEMBER 31, 2018

Priority Aviation, Inc. and Subsidiaries Consolidated Financial Statements For the Three Months Ended March 31, 2017 and (Unaudited) Contents

SONASOFT CORPORATION FINANCIAL STATEMENTS DECEMBER 31, 2016 AND 2015


Lead Innovation Corporation Consolidated Balance Sheets (Unaudited) Current Assets: Cash and cash equivalents $ 66,835 $ -

Viratech Corp. and Subsidiaries

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q/A Amendment No. 1

Pyramidion Technology Group, Inc. OTC Pink Quarterly Report and Disclosure Statement June 30, 2018

BIOADAPTIVES, INC. CONSOLIDATED BALANCE SHEETS

CAREVIEW COMMUNICATIONS, INC. (Exact name of registrant as specified in its charter)

Benjamin F. Edwards & Company, Inc. (A Wholly Owned Subsidiary of Benjamin Edwards, Inc.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q

JLM Couture, Inc. and Subsidiaries. Consolidated Financial Report January 31, 2018

MEDICAL IMAGING CORP. (Exact name of registrant as specified in charter)

THERAPY CELLS INC FORM 10-Q. (Quarterly Report) Filed 09/22/11 for the Period Ending 09/30/10

DIGITAL UTILITIES VENTURES, INC. February 28, 2018 Quarterly Report

EDGAR Submission Header Summary

RADA ELECTRONIC INDUSTRIES LTD. AND ITS SUBSIDIARIES CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2018 U.S. DOLLARS IN THOUSANDS

ARTVENTIVE MEDICAL GROUP, INC. (Filer) CIK:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C For the quarterly period ended March 31, 2013 or

APOLLO ENTERPRISE SOLUTIONS, LTD. and SUBSIDIARY. Consolidated Financial Statements. December 31, 2017 and With Independent Auditors Report

PERSHING RESOURCES COMPANY, INC. AND SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q

JLM Couture, Inc. and Subsidiaries. Consolidated Financial Report July 31, 2018

Robert W. Baird & Co. Incorporated. Unaudited Consolidated Statement of Financial Condition As of June 30, 2018

Splash Beverage Group, Inc. A Nevada Corporation. Financial Statements and Independent Accountant s Review Report December 31, 2016 and 2015

CORINDUS VASCULAR ROBOTICS, INC. (Exact name of registrant as specified in its charter)

JLM Couture, Inc. and Subsidiaries. Unaudited Consolidated Financial Report July 31, 2016

Independent Auditor s Review Report

CONTACTUAL, INC. AND SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) For the Six Months Ended June 30, 2011

Vantiv, Inc. (Exact name of registrant as specified in its charter)

Annual Report. December 31, 2017 and Table of Contents

TGR Financial, Inc. and Subsidiaries. Financial Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q. (Mark One)

Borr Drilling Limited and subsidiaries

Social Life Network, Inc. Unaudited Financial Statements for the

KYN CAPITAL GROUP INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2016 AND 2015 (UNAUDITED)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. NaturalShrimp Inc. Form: 10-Q. Date Filed:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 10-Q

APPALACHIAN MOUNTAIN BREWERY, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2014 AND 2013

C ONSOLIDATED F INANCIAL S TATEMENTS. Billing Services Group Limited Years Ended December 31, 2010 and 2009 With Report of Independent Auditors

VISA INC. (Exact name of Registrant as specified in its charter)

FORM 10-Q. PROSPER MARKETPLACE, INC. (Exact name of registrant as specified in its charter)

Transcription:

SIMPLY INNOVATIVE PRODUCTS, INC. (FORMERLY COASTAL INTEGRATED SERVICES, INC.) FINANCIAL STATEMENTS March 31, 2018

SIMPLY INNOVATIVE PRODUCTS, INC. BALANCE SHEET (unaudited) March 31, December 31, Assets: 2018 2017 Current Assets Cash $ 43,194 $ 43,194 Inventory 32,643 32,643 Total Current Assets 75,837 75,837 Non-Current Assets Equipment 194,300 194,300 Intangible Assets 696,604 562,060 Total Non-Current Assets 890,904 756,360 Total Assets $966,741 $ 832,197 Liabilities: Related Party Loan $ 365,676 $ 365,676 Consulting Agreements Deposits 500,000 14,000 500,000 14,000 Note Payable 103,974 91,974 Accrued Expenses 5,000 5,000 Total Current Liabilities 988,650 976,650 Total Liabilities 988,650 976,650 Stockholders Equity: Common Stock, 500,000,000 authorized @ $0.0001 431,266 264,904 issued and outstanding 43,126,607 Preferred Stock, 20,000,000 Authorized @ $0.001 10,000 10,000 10,000,000 issued Additional Paid in Capital 1,649,724 1,649,724 (Deficit) Accumulated During the Developmental Stage (2,069,081) (2,069,081) Total Stockholders Equity (Deficit) (21,909) (144,453) Total Liabilities and Stockholders Equity $ 966,741 $ 832,197 The accompanying notes are an integral part of these financial statements.

SIMPLY INNOVATIVE PRODUCTS, INC. STATEMENTS OF OPERATIONS (unaudited) For the year ended March 31, For the three months ended March 31, 2018 2017 Revenue-Consulting $ 2,117 $177 Operating Expenses: Selling, General and Administrative Expenses 17,411 49,625 Total Operating Expenses - Operating Profit (Loss) (15,294) (49,448) Other Expense: Financing Cost - - Net Profit (Loss) $ (15,294) $ (49,448) Net (loss) Profit per Share (0.00) (0.00) Weighted Average Shares Outstanding 46,986,607 295,862 The accompanying notes are an integral part of these financial statements.

SIMPLY INNOVATIVE PRODUCTS, INC. STATEMENT OF STOCKHOLDERS EQUITY (unaudited) Common Shares Total Additional Paid Preferred Retained Total in Capital Stock Earnings Balance December 31, 2013 1,000 $1,000 - - $(182,648) $(181,648) Stock issued for debt 52,418,000 5,242 47,176 52,418 Merger (1,000) (1,000) 1,000 - - Effects of Reverse Merger 300,069,904 30,007 (68,425) 10,000 - (28,418) Net loss for the year (78,142) (78,142) Balance December 31, 2014 352,487,904 35,249 (20,249) 10,000 (260,790) (235,790) Shares issued for debt 73,670,006 7,367 787,973 795,340 Shares issued for services 60,000,000 6,000 222,000 228,000 Net loss for the year (1,185,308) (1,185,308) Balance December 31, 2015 486,157,910 48,616 989,724 10,000 (1,446,098) (397,758) Shares issued for debt 640,000,000 64,000 64,000 Shares issued for services 900,000,000 90,000 420,000 510,000 Shares issued for purchase of assets 400,000,000 40,000 240,000 280,000 Net loss for the year (545,523) (545,523) Balance December 31, 2016 2,426,157,910 242,616 1,649,724 10,000 (1,991,621) (89,281) Effect of reverse split (2,425,187,447) Adjustment to shares 16,141 Shares issued for debt 4,000,000 20,000 20,000 Shares issued 23,060,000 2,288 2,288 Net loss for the period (77,460) (77,460) Balance December 31, 2017 28,046,604 $264,904 $1,649,724 $10,000 $(2,069,081) $(144,453) Shares issued for services 15,000,000 Shares issued 3,940,003 Balance March 31, 2018 46,986,607 $264,904 $1,649,724 $10,000 $(2,069,081) $(144,453) The accompanying notes are an integral part of these financial statements.

CASH FLOW FROM OPERATING ACTIVITES: SIMPLY INNOVATIVE PRODUCTS, INC. STATEMENTS OF CASH FLOWS (unaudited) For the year ended March 31, 2018 For the three months ended March 31, 2017 Net Profit ( Loss) for the Period $ (15,294) $ (49,448) Adjustments to reconcile net loss to net cash used by operating activities: Stock issued for services Increase (Decrease) in Accrued Expenses 712 2,998 Increase in Deposits Net Cash Provided from Operating Activities $(14,582) $(42,450) CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of Equipment, Inventory and Patent - 1,443 Net Cash Used by Investing Activities - 1,443 CASH FLOWS FROM FINANCING ACTIVITIES: Deposit for shares issued in April 2017-14,000 Loans from Related Party - (153) Loans from third parties $38,900 27,568 Net Cash Used by Financing Activities 38,900 39,972 Net (Decrease) Increase in Cash 38,900 (6,478) Cash at Beginning of Period 4,294 6,934 Cash at End of Period $ 44,194 $456 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid during the period for: Interest $500 250 Stock issued for Debt - The accompanying notes are an integral part of these financial statements.

SIMPLY INNOVATIVE PRODUCTS, INC. NOTES TO FINANCIAL STATEMENTS September 30, 2017 (unaudited) NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Simply Lids (the Company ) was incorporated on August 27, 2013. On May 30, 2014 the Company entered into a share exchange agreement with Coastal Integrated Services, a publicly traded company, incorporated in Wyoming. For accounting purposes the share exchange agreement is being treated as a reverse merger. Hence, the accounting information that is presented is that of the surviving entity, which is Simply Lids. The Company has developed a patent pending leak resistant, re-closable lid designed to provide the ultimate drinking experience. NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (A) Basis of Presentation The Company s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ( U.S. GAAP ). (B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment, estimate of fair value of share based payments and derivative instruments and recorded debt discount, valuation of deferred tax assets and valuation of in-kind contribution of services and interest. (C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At March 31, 2018 and December 31, 2017, the Company had no cash equivalents. (D) Loss Per Share In accordance with the accounting guidance now codified as FASB ASC Topic 260, Earnings per Share basic loss per share is computed by dividing net loss by weighted average number of shares of common stock outstanding during each period. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. The computation of basic and diluted loss per share at March 31, 2018 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: (E) Operating Leases The Company leases office space on a month to month basis. The total cost is included in general and administrative expenses. (F) Business Segments The Company operates in one segment and therefore segment information is not presented.

(G) Revenue Recognition The Company will recognize revenue on arrangements in accordance with FASB ASC No. 605, Revenue Recognition. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. (H) Fair Value of Financial Instruments The Company applies the accounting guidance under Financial Accounting Standards Board ( FASB ) ASC 820-10, Fair Value Measurements, as well as certain related FASB staff positions. This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. The guidance also establishes a fair value hierarchy for measurements of fair value as follows: Level 1 - quoted market prices in active markets for identical assets or liabilities. Level 2 - inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 - unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company's financial instruments consist of accounts payable, accrued expenses, notes payable, notes payable - related party, loan payable - related party, convertible notes payable, convertible notes payable - related party and deferred rent payable. The carrying amount of the Company's financial instruments approximates their fair value as of March 31, 2018, due to the short-term nature of these instruments. The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 3 (see Note 8). (I) Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under ASC 815 Derivatives and Hedging to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 Debt with Conversion and Other Options for consideration of any beneficial conversion features. (J) Derivative Financial Instruments Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In

addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model. (K) Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid in capital) and amortized to interest expense over the life of the debt. (L) Debt Issue Costs and Debt Discount The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. (M) Stock-Based Compensation - Non Employees Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Sub-topic 505-50 of the FASB Accounting Standards Codification ( Sub-topic 505-50 ). Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. If the Company is a newly formed corporation or shares of the Company are thinly traded the use of share prices established in the Company s most recent private placement memorandum ( PPM ), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes optionpricing valuation model. The ranges of assumptions for inputs are as follows: Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder s expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder s expected exercise behavior. If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. Expected volatility of the entity s shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected

contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments. Pursuant to ASC paragraph 505-50-25-7, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic. Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a share option and similar instrument that the counterparty has the right to exercise expires unexercised. Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded. (N) Recent Accounting Pronouncements In June 2014, FASB issued Accounting Standards Update ( ASU ) No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The update removes all incremental financial reporting requirements from GAAP for development stage entities, including the removal of Topic 915 from the FASB Accounting Standards Codification. In addition, the update adds an example disclosure in Risks and Uncertainties (Topic 275) to illustrate one way that an entity that has not begun planned principal operations could provide information about the risks and uncertainties related to the company s current activities. Furthermore, the update removes an exception provided to development stage entities in Consolidations (Topic 810) for determining whether an entity is a variable interest entity-

which may change the consolidation analysis, consolidation decision, and disclosure requirements for a company that has an interest in a company in the development stage. The update is effective for the annual reporting periods beginning after December 15, 2014, including interim periods therein. Early application with the first annual reporting period or interim period for which the entity s financial statements have not yet been issued (Public business entities) or made available for issuance (other entities). The Company adopted this pronouncement for the three months ended August 31, 2014. In June 2014, FASB issued Accounting Standards Update ( ASU ) No. 2014-12, Compensation Stock Compensation (Topic 718); Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in this ASU apply to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. For all entities, the amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. Entities may apply the amendments in this ASU either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. If retrospective transition is adopted, the cumulative effect of applying this Update as of the beginning of the earliest annual period presented in the financial statements should be recognized as an adjustment to the opening retained earnings balance at that date. Additionally, if retrospective transition is adopted, an entity may use hindsight in measuring and recognizing the compensation cost. This updated guidance is not expected to have a material impact on our results of operations, cash flows or financial condition. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In August 2014, the FASB issued Accounting Standards Update ASU 2014-15 on Presentation of Financial Statements Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity s Ability to Continue as a Going Concern. Currently, there is no guidance in U.S. GAAP about management s responsibility to evaluate whether there is substantial doubt about an entity s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this Update provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable. NOTE 3 - GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As of March 31, 2018, the Company had an accumulated deficit, minimal sales and limited assets. These factors raise substantial doubt about the Company s ability to continue as a going concern. While the Company is continuing operations, the Company s cash position may not be significant enough to support the Company s daily operations. Management intends to raise additional funds by way of a public or private offering.

Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. NOTE 4- Non-Current Assets Non-Current Assets During the period, the company purchased no assets. Related Party Loan The Company is advanced funds by its officers and incurs consulting fees. At March 31, 2018, the Company was indebted to its officers for loans of $365,676 (September 30, 2017, $365,676). Terms indicate payment on demand without interest. Office Space An officer provides office space to the Company on a month to month basis for $1,500 per month. Stock Issuance On April 19, 2017, the company issued 5 private investors 1,800,000 restricted common shares. On April 19, 2017, the company issued 3 private investors 180,000 restricted common shares. On April 21, 2017, the company issued 5 private investors 6,800,000 restricted common shares. On April 21, 2017, the company issued 5 private investors 8,200,000 restricted common shares. On April 26, 2017, the company issued 6 private investors 6,080,000 restricted common shares. On May 15, 2017, the company issued 2,000,000 common shares to resolve partial $10,000 of the issuer s debt. On June 26, 2017, the company issued 2,000,000 common shares to resolve partial $10,000 of the issuer s debt. On July 27, 2017, the company issued 1 private investor 80,000 restricted common shares. On November 3, 2017, the company issued 2 officers 15,000,000 restricted common shares for deferred compensation. The Company s preferred stock is issued to one of its officers. NOTE 5 NOTE PAYABLE At December 31, 2017, the Company is obligated on a demand note payable to third parties for $53,074, inclusive of interest (June 30, 2017, $52,362). The company has seven demand notes payable to third parties for a total of $38,900 (Sept.22, 2017 $6,000, Dec.2, 2016 $6500, May 23, 2017 $4,000, June 16, 2017 $3,000, Aug. 7, 2017 $6,000, Sept. 28, 2017 $7,400, Nov. 28, 2017 $6,000) March 28, 2018 $12,000

NOTE 6 STOCKHOLDERS EQUITY Common Stock Authorized The Company is authorized to issue 500,000,000 shares of common stock with a par value of $0.0001. Common Stock Issued On May 30, 2014 the Company effectuated a reverse merger of which 300,000,000 shares were issued to fractional shares existing of 69,904. On May 27, 2014 the Company issued 28,418,000 shares for the reduction of debt assumed by the Company in the reverse. On June 24, 2014 the Company issued 24,000,000 shares to satisfy a debt incurred of $24,000. At December 31, 2014, the Company had outstanding shares of 352,487,904. On August 19, 2015 the Company issued 40,000,000 shares for debt reduction of $8,000. The debt was paid at a share price of $0.0002. The market price was 0.0182. The Company has recognized a financing cost for the difference between the market price and the cost it was offered for or.018 per share equaling $720,000. On September 25,2015, the Company issued 33,670,006 shares of stock for a debt reduction of $6,734. The difference between the market price and the conversion price amounted to a financing charge of $60,606. On October 2, 2015 the Company issued 60,000,000 shares of stock to its two officers for services valued at market price of $0.0038 per share or $228,000. On March 23, 2016 the Company issued 600,000,000 shares of stock to its two officers for services valued at market price of $0.0004 per share or $240,000. On April 1, 2016, the Company issued 300,000,000 shares for debt reduction of $30,000. On April 11, 2016, the Company issued 200,000,000 shares for debt reduction of $20,000. On July 27, 2016 the Company issued 300,000,000 shares of stock to its two officers for services valued at a market price of $0.0009 per share or $270,000. On August 22, 2016 the Company issued 140,000,000 shares for debt reduction of 14,000. On September 19, 2016, the Company issued 400,000,000 shares for the Bugout Acquisition valued at market price of $0.0007 per share or $280,000. On February 6, 2017, FINRA approved a common stock reverse split of 2,500 for 1, a new name, Simply Innovative Products, Inc., a new CUSIP 82900H101 and symbol change. On March 8, 2017, FINRA approved a new trading symbol SMPI. On April 19, 2017, the company issued 5 private investors 1,800,000 restricted common shares valued at market price of $178. On April 19, 2017, the company issued 3 private investors 180,000 restricted common shares valued at market price of $18. On April 21, 2017, the company issued 5 private investors 6,800,000 restricted common shares valued at market price of $675. On April 21, 2017, the company issued 5 private investors 8,200,000 restricted common shares valued at market price of $814.

On April 26, 2017, the company issued 6 private investors 6,080,000 restricted common shares valued at market price of $603. On May 15, 2017, the company issued 2,000,000 shares for debt reduction of $10,000. On June 26, 2017, the company issued 2,000,000 shares for debt reduction of $10,000. On July 27, 2017, the company issued 1 private investor 80,000 restricted common shares. On November 3, 2017, the company issued 2 officers 15,000,000 restricted common shares for deferred compensation. Preferred Stock At September 30, 2014 the Company has authorized 20,000,000 shares of which 10,000,000 are issued. The preferred may be converted to common at 100 shares of common to 1 share of preferred or 100 to 1. NOTE 7 CONSULTING AGREEMENTS On March 1, 2017 SMPI entered into a consulting agreement with Mark Cheung. Consultant has experience in the management and regulatory maintenance of Pink sheet companies as well as in business law. The term ended September 1, 2017. Subject to the terms and conditions of the Agreement, the Client will pay Two Hundred & Fifty Thousand U.S. Dollars (US$250,000.00) to Consultant (the Price ). At the election of Consultant by demand to Client at any time, and in lieu of the payment of funds to Consultant, Client shall pay to Consultant such amount of shares of Client s common stock (presently listed and traded under the SMPI ticker symbol) based upon the closing price per share of SMPI common stock at OTC Markets on the date of the conversion demand, but discounted fifty percent (50%). Said shares are considered fully earned effective on the date of execution of this agreement. On March 1, 2017 SMPI entered into a consulting agreement with Charlie Abujudeh. Consultant has experience in the management and regulatory maintenance of Pink sheet companies as well as in product development and marketing. The term ended September 1, 2017. Subject to the terms and conditions of the Agreement, the Client will pay Two Hundred & Fifty Thousand U.S. Dollars (US$250,000.00) to Consultant (the Price ). At the election of Consultant by demand to Client at any time, and in lieu of the payment of funds to Consultant, Client shall pay to Consultant such amount of shares of Client s common stock (presently listed and traded under the SMPI ticker symbol) based upon the closing price per share of SMPI common stock at OTC Markets on the date of the conversion demand, but discounted fifty percent (50%). Said shares are considered fully earned effective on the date of execution of this agreement. NOTE 8 INCOME TAX Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Net deferred tax assets consist of the following components as of March 31, 2018:

Deferred Tax Assets Non-current: March 31, 2018 Dec. 31, 2017 NOL Carryover $192,806 $192,806 Less valuation allowance (192,806) (192,806) Deferred tax assets, net of valuation allowance - - The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the period ended September 30, 2017 due to the following: March 31, 2018 2017 Book Income $(0) $(0) Other nondeductible expenses Valuation allowance 0 0 $ - $ - At March 31, 2018, the Company had net operating loss carryforwards of approximately $370,475 that may be offset against future taxable income from the year 2018 to 2038. No tax benefit has been reported in the March 31, 2018 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal Income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carryforwards may be limited as to use in future years. NOTE 9 SUBSEQUENT EVENTS Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that no material subsequent events exist.